Answers are grounded in this paper and cite their sources.
Assesses diagnostic efficacy of blood indicators for pneumonia risk in children, indicating practical diagnostic improvements.
BACKGROUND: This study assessed the diagnostic value of complete blood count (CBC) and derived immune-inflammatory indicators for Mycoplasma pneumoniae pneumonia (MPP) in children and developed a practical scoring system for early diagnosis. METHODS: A total of 1662 MP-infected children were divided into pneumonia (n = 844) and non-pneumonia (n = 818) groups. CBC parameters, derived immune-inflammatory indicators and C-reactive protein (CRP) were compared. Diagnostic performance was assessed using ROC curve analysis, and diagnostic models were constructed using multivariate logistic regression. Age-stratified analysis addressed confounding. Model stability was evaluated via repeated stratified 10-fold cross-validation, calibration curves with Brier score, and decision curve analysis (DCA). A simplified scoring system was established and validated for clinical application. RESULTS: Children in the pneumonia group were significantly younger (mean age 5.78 ± 3.41 years vs. 8.62 ± 4.92 years, p < 0.001). Lymphocyte count (LYM), lymphocyte percentage (LYM%), platelet count (PLT), plateletcrit (PCT), and the product of absolute lymphocyte count and platelet count (PLT × LYM) in the pneumonia group were significantly higher than in the non-pneumonia group. Age-stratified analysis confirmed these differences across all age subgroups (all p < 0.001). PLT × LYM, LYM%, PLT, and PCT were independent predictors. Internal validation showed a mean AUC of 0.7824 ± 0.0353, good calibration (Brier score = 0.1918 ± 0.0164), and positive net benefit on DCA. The scoring system achieved diagnostic rates of 71.5%, 51.2%, and 29.6% for high-, medium-, and low-risk groups, respectively. CONCLUSION: MPP predominantly affects children under 7 years old. The simple scoring system, supported by robust internal validation, effectively stratifies pneumonia risk and offers a practical early diagnostic tool for primary care.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: